UOTTAIMCU
VIR icon

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Vir Biotechnology VIR Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-130,409
Closed -$2.51M – 74
2022
Q3 		$2.51M Buy
+130,409
New +$3.32M 0.94% 7
2022
Q1 		– Sell
-290,736
Closed -$12.2M – 41
2021
Q4 		$12.2M Buy
+290,736
New +$11.4M 5.53% 5
2021
Q2 		– Sell
-94,513
Closed -$4.85M – 25
2021
Q1 		$4.85M Buy
+94,513
New +$5.09M 2.84% 8

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s VIR Position: Q4 2022 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Vir Biotechnology (VIR) in Q4 2022, closing a stake of 130,409 shares — an estimated $2.51M sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in VIR in Q1 2021 and held it in 3 quarters. The position peaked at $12.2M in Q4 2021. 224 funds tracked by Wall St. Rank hold VIR as of Q4 2022.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Vir Biotechnology position as of Q4 2022 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 130,409 Vir Biotechnology shares in Q4 2022, an estimated $2.51M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Vir Biotechnology in Q1 2021 and held it in 3 quarters.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Vir Biotechnology position peaked at $12.2M in Q4 2021.
  • 224 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2022.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q4 2022, filed 14 Feb 2023.